Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
Tactile Systems Technology Community
NasdaqGM:TCMD Community
1
Narratives
written by author
0
Comments
on narratives written by author
13
Fair Values set
on narratives written by author
Create a narrative
Tactile Systems Technology
Popular
Undervalued
Overvalued
Community Investing Ideas
Tactile Systems Technology
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Nimbl Platform Launch Will Drive Lymphedema Treatment Adoption And Market Expansion
Key Takeaways Market development and clinician training efforts are expanding reach and driving revenue growth opportunities for lymphedema care. The Nimbl platform and strong clinical evidence support increased product adoption and influence payer policies, potentially enhancing market access and revenue streams.
View narrative
US$21.50
FV
37.9% undervalued
intrinsic discount
8.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
7 days ago
author updated this narrative
Your Valuation for
TCMD
TCMD
Tactile Systems Technology
Your Fair Value
US$
Current Price
US$13.35
9.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-18m
439m
2015
2018
2021
2024
2025
2027
2030
Revenue US$439.0m
Earnings US$25.4m
Advanced
Set Fair Value